Raul Santos, MD, PhD

Raul Santos Filho

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: AMGEN(SIGNIFICANT), Kowa(MODEST), Sanofi/Regeneron(SIGNIFICANT), Novo-Nordisk(MODEST), Merck(MODEST), AstraZeneca Pharmaceuticals(MODEST), Ache(MODEST), PTC(MODEST), Novartis Corporation(MODEST) SPEAKER'S BUREAU: Pfizer(MODEST), EMS(SIGNIFICANT), Libbs (SIGNIFICANT), GETZ Pharma(MODEST) RESEARCH/RESEARCH GRANTS: Esperion(SIGNIFICANT)

View Full Disclosure